Condition: Early Onset Alzheimer Disease · Alzheimer Disease · Mild Cognitive Impairment · Sponsor: Indiana University
The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is a non-randomized, natural history, non-treatment study designed to look at disease progression in individuals with early onset cognitive impairment. Clinical, cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EOnonAD) participants, and (3) cognitively normal (CN) control participants.
This description comes directly from the study's public registry record.
IU LEADS Team · 317-963-7436 · iuLEADS@iupui.edu
Always discuss trial participation with your own doctor first.
| Banner Sun Health Research Institute | Sun City, Arizona, United States | Completed |
| University of California, Los Angeles | Los Angeles, California, United States | Recruiting |
| Stanford University | Palo Alto, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Georgetown University | Washington D.C., District of Columbia, United States | Completed |
| Mayo Clinic, Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Wien Center | Miami Beach, Florida, United States | Completed |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Completed |
| Indiana University | Indianapolis, Indiana, United States | Recruiting |
| Johns Hopkins University | Baltimore, Maryland, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03507257